To understand whether CD84 knockdown could also affect the ability of AML cells to engraft, we downregulated CD84 in luciferase-expressing THP1 cells and transplanted the cells into immunodeficient NSG mice. The gene discussed is CD84; the disease is acute myeloid leukemia.